189 related articles for article (PubMed ID: 19344395)
1. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
Bonney D; Razali H; Turner A; Will A
Br J Haematol; 2009 Jun; 145(5):667-9. PubMed ID: 19344395
[No Abstract] [Full Text] [Related]
2. Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.
Kitanovski L; Kopriva S; Pokorn M; Dolničar MB; Rajić V; Stefanović M; Jazbec J
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e311-3. PubMed ID: 23669731
[TBL] [Abstract][Full Text] [Related]
3. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child.
Shachor-Meyouhas Y; Ben-Barak A; Kassis I
Pediatr Blood Cancer; 2011 Aug; 57(2):350-1. PubMed ID: 21671370
[No Abstract] [Full Text] [Related]
4. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
Ortega JJ; Javier G; Olivé T
An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
[No Abstract] [Full Text] [Related]
5. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients.
Safdar A
Bone Marrow Transplant; 2008 Apr; 41(8):707-8. PubMed ID: 18347567
[No Abstract] [Full Text] [Related]
6. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
Saito T; Seo S; Kanda Y; Shoji N; Ogasawara T; Murakami J; Tanosaki R; Tobinai K; Takaue Y; Mineishi S
Am J Hematol; 2001 Jul; 67(3):206-9. PubMed ID: 11391721
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
Campana D; Pui CH
Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
[No Abstract] [Full Text] [Related]
8. Tuberculosis and immune thrombocytopenia.
Madkaikar M; Ghosh K; Jijina F; Gupta M; Rajpurkar M; Mohanty D
Haematologica; 2002 Aug; 87(8):ELT38. PubMed ID: 12161383
[No Abstract] [Full Text] [Related]
9. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E
Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086
[No Abstract] [Full Text] [Related]
10. [Study on the treatment of acute lymphoblastic leukemia with T-cell markers in children].
Nishikawa A; Saito K; Taniuchi S; Ohnishi T; Matsumura T
Rinsho Ketsueki; 1984 May; 25(5):660-5. PubMed ID: 6332214
[No Abstract] [Full Text] [Related]
11. [L-asparaginase therapy against hybrid leukemia: a case report].
Mitani K; Kobayashi Y; Kawamura Y; Usuki K; Yuo A; Ishikawa F; Kitamura T; Ozawa K; Kitamura K; Urabe A
Rinsho Ketsueki; 1988 Sep; 29(9):1442-6. PubMed ID: 3216516
[No Abstract] [Full Text] [Related]
12. Chemotherapy-induced leukonychia.
Benatti C; Gnocchi M; Travaglino E; Invernizzi R; Ascari E
Haematologica; 2004 Jul; 89(7):EIM16. PubMed ID: 15257962
[No Abstract] [Full Text] [Related]
13. Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia.
Esmer O; Karadag R; Soylu E; Oner AF; Burakgazi-Dalkilic E
Cutan Ocul Toxicol; 2013 Oct; 32(4):330-2. PubMed ID: 23461596
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
[TBL] [Abstract][Full Text] [Related]
15. Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Cheuk DK; Shek TW; Chan GC; Lau YL; Ha SY; Chiang AK
Pediatr Blood Cancer; 2008 Mar; 50(3):636-9. PubMed ID: 16865683
[TBL] [Abstract][Full Text] [Related]
16. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
Fu RY; Liao QK; Jia CS
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
[No Abstract] [Full Text] [Related]
17. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.
Steiner I; Aebi C; Ridolfi Lüthy A; Wagner B; Leibundgut K
Pediatr Blood Cancer; 2008 Mar; 50(3):647-9. PubMed ID: 17278117
[TBL] [Abstract][Full Text] [Related]
18. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
[TBL] [Abstract][Full Text] [Related]
19. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
Appel IM; Hop WC; Pieters R
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
[TBL] [Abstract][Full Text] [Related]
20. RSV infection complicating the therapy of pediatric malignancies: report of six cases.
Vettenranta K; Ukkonen P; Saarinen UM
Med Pediatr Oncol; 1996 Apr; 26(4):261-3. PubMed ID: 8600339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
